Evidence map›Paper›PMID 25903014›Full record

ArticleJournal of hematology & oncology2015

Deep sequencing and SNP array analyses of pediatric T-cell acute lymphoblastic leukemia reveal NOTCH1 mutations in minor subclones and a high incidence of uniparental isodisomies affecting CDKN2A.

Kristina Karrman, Anders Castor, Mikael Behrendtz, Erik Forestier, Linda Olsson, Mats Ehinger, Andrea Biloglav, Thoas Fioretos, Kajsa Paulsson, Bertil Johansson

Open access · goldAbstract read
In one paragraph

Article in Journal of hematology & oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. SNP Array in Hematopoietic Neoplasms: A Review.Microarrays (Basel, Switzerland) · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Kristina KarrmanDepartment of Clinical Genetics, University and Regional Laboratories, Region Skåne, SE-221 85, Lund, Sweden. Kristina.Karrman@med.lu.se.
Anders CastorDepartment of Pediatrics, Skåne University Hospital, Lund University, Lund, Sweden. Anders.Castor@skane.se.
Mikael BehrendtzDepartment of Pediatrics, Linköping University Hospital, Linköping, Sweden. Mikael.Behrendtz@lio.se.
Erik ForestierDepartment of Medical Biosciences, Clinical Genetics, Umeå University, Umeå, Sweden. Erik.Forestier@medbio.umu.se.
Linda OlssonDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden. Linda.Olsson@med.lu.se.
Mats EhingerDepartment of Pathology, University and Regional Laboratories, Region Skåne, Lund, Sweden. Mats.Ehinger@skane.se.
Andrea BiloglavDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden. Andrea.Biloglav@med.lu.se.
Thoas FioretosDepartment of Clinical Genetics, University and Regional Laboratories, Region Skåne, SE-221 85, Lund, Sweden. Thoas.Fioretos@med.lu.se.
Kajsa PaulssonDivision of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden. Kajsa.Paulsson@med.lu.se.
Bertil JohanssonDepartment of Clinical Genetics, University and Regional Laboratories, Region Skåne, SE-221 85, Lund, Sweden. Bertil.Johansson@med.lu.se.
Lund University · SELinköping University · SESkåne University Hospital · SEUmeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPediatric T-cell acute lymphoblastic leukemia (T-ALL) is a genetically heterogeneous disease that arises in a multistep fashion through acquisition of several genetic aberrations, subsequently giving rise to a malignant, clonal expansion of T-lymphoblasts. The aim of the present study was to identify additional as well as cooperative genetic events in T-ALL.

methodsA population-based pediatric T-ALL series comprising 47 cases was investigated by SNP array and deep sequencing analyses of 75 genes, in order to ascertain pathogenetically pertinent aberrations and to identify cooperative events.

resultsThe majority (92%) of cases harbored copy number aberrations/uniparental isodisomies (UPIDs), with a median of three changes (range 0-11) per case. The genes recurrently deleted comprised CDKN2A, CDKN2B, LEF1, PTEN, RBI, and STIL. No case had a whole chromosome UPID; in fact, literature data show that this is a rare phenomenon in T-ALL. However, segmental UPIDs (sUPIDs) were seen in 42% of our cases, with most being sUPID9p that always were associated with homozygous CDKN2A deletions, with a heterozygous deletion occurring prior to the sUPID9p in all instances. Among the 75 genes sequenced, 14 (19%) were mutated in 28 (72%) of 39 analyzed cases. The genes targeted are involved in signaling transduction, epigenetic regulation, and transcription. In some cases, NOTCH1 mutations were seen in minor subclones and lost at relapse; thus, such mutations can be secondary events.

conclusionsDeep sequencing and SNP array analyses of T-ALL revealed lack of wUPIDs, a high proportion of sUPID9p targeting CDKN2A, NOTCH1 mutations in subclones, and recurrent mutations of genes involved in signaling transduction, epigenetic regulation, and transcription.

Indexed as

Cyclin-Dependent Kinase Inhibitor p16FemaleHumansIncidenceMalePolymorphism, Single NucleotidePrecursor T-Cell Lymphoblastic Leukemia-LymphomaReceptor, Notch1Uniparental DisomyCyclin-Dependent Kinase Inhibitor p16NOTCH1 protein, humanReceptor, Notch1

Identifiers

PMID25903014
PMCPMC4412034
OpenAlexW2127211569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.